OPHLF News and Press, Ono Pharmaceutical Co Ltd

2026-02-17 09:11:22 ET More on Pfizer Pfizer: A Great Opportunity Post Earnings Pfizer: 'Hold' As Patent Cliff Looms, Along With Need For Differentiating Factor In Obesity Pfizer Inc. 2025 Q4 - Results - Earnings Call Presentation Changes to U.S. vaccine poli...

2026-02-02 01:11:53 ET More on Ono Pharmaceutical Co., Ltd. Ono Pharmaceutical Co., Ltd. (OPHLY) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Ono Pharmaceutical Co., Ltd. (OPHLY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript ...

2026-01-14 18:16:01 ET Ono Pharmaceutical Co., Ltd. (OPHLY) 44th Annual J.P. Morgan Healthcare Conference January 14, 2026 2:15 PM EST... Read the full article on Seeking Alpha For further details see: Ono Pharmaceutical Co., Ltd. (OPHLY) Presents at 44th Annual J.P. Morgan ...

2025-08-03 21:36:32 ET Ono Pharmaceutical Co., Ltd. (OPHLF) Q1 FY2025 Earnings Conference Call August 01, 2025 01:00 AM ET Company Participants Hirokazu Kitada - Corporate Participant Sales and Marketing - Corporate Participant Hiroyuki Takahashi - Director of On...

2025-08-01 08:50:55 ET More on Ono Pharmaceutical Co., Ltd. Ono Pharmaceutical Co., Ltd. 2025 Q4 - Results - Earnings Call Presentation Vertex and Ono Pharmaceutical form exclusive alliance for Povetacicept in Japan and South Korea Historical earnings data for Ono Ph...

FAT Brands Inc. (FAT) is expected to report $-2.56 for Q2 2025 Asahi Kasei Corp ADR (AHKSY) is expected to report for Q1 2026 Nabtesco Corp. (NCTKF) is expected to report for Q2 2025 Summit State Bank (SSBI) is expected to report for Q2 2025 Compass Inc. Class A (COMP) is expected...

Ono Pharmaceutical Co. Ltd (OPHLF) is expected to report for Q1 2026

2025-06-23 04:50:15 ET Vertex Pharmaceuticals ( Nasdaq: NASDAQ: VRTX ) and Ono Pharmaceutical ( OTCMKTS: OTCPK:OPHLY ) have announced an exclusive collaboration, for the development and commercialization of Vertex's povetacicept in Japan and South Korea.... Re...

Replimune Group Inc. (REPL) is expected to report $-0.75 for Q4 2025 Adcore (ADCOF) is expected to report for Q1 2025 Equillium Inc. (EQ) is expected to report $-0.22 for Q1 2025 Credicorp Ltd. (BAP) is expected to report $5.31 for Q1 2025 Pelangio Exploration Inc (PGXPF) is expec...

Ironwood Pharmaceuticals Inc. (IRWD) is expected to report $-0.05 for Q1 2025 CaliberCos Inc. (CWD) is expected to report $-0.4 for Q1 2025 BlackRock TCP Capital Corp. (TCPC) is expected to report $0.34 for Q1 2025 INmune Bio Inc. (INMB) is expected to report $-0.43 for Q1 2025 No...